Harmony BiosciencesHRMY

那斯達克 · USD
42.25
+0.39
(+0.93%)
收盤 09/05 03:59 (UTC+8)
09/05 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.55
  • 1.73
  • 1.86
  • 2.01
  • 1.85
  • 2.00
  • 2.39
  • 2.44
  • 2.15
  • 2.61
icon
  • -8.19
  • 11.77
  • 7.65
  • 8.19
  • -8.21
  • 8.53
  • 19.44
  • 1.80
  • -11.65
  • 21.31
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
261,280
215,387
243,776
239,455
200,489
184,733
201,267
186,038
172,814
154,615
營業成本
63,19844,51268,54559,65038,15331,99454,40942,77832,14427,484
營業毛利
198,082
170,875
175,231
179,805
162,336
152,739
146,858
143,260
140,670
127,131
營業費用
108,766133,584136,674114,318114,15696,494-81,550-75,098
研發費用
46,59669,38349,93354,96250,15934,54034,66625,38763,58322,189
推銷及管理費用
62,17064,20186,74159,35663,99761,95456,46556,16355,73152,909
非經常性項目費用
----------
其他營業費用
----------
營業利益
89,316
37,291
38,557
65,487
48,180
56,245
55,727
61,710
21,356
52,033
其他收入及費用
7,0195,6305,7495,6245,1034,7684,6374,8084,7424,287
利息費用
3,0703,2343,5463,6213,6463,8364,2094,3484,4044,535
稅前純益
93,265
39,687
40,760
67,490
49,637
57,177
56,155
62,170
21,694
51,785
所得稅
17,8347,19918,27416,6259,86111,6176,68016,07710,10313,451
稅後純益
75,431
32,488
22,486
50,865
39,776
45,560
49,475
46,093
11,591
38,334
基本每股稅後盈餘(元)
1.300.560.390.880.690.790.870.810.200.68
稀釋每股稅後盈餘(元)
1.290.550.390.870.680.780.850.790.200.67
基本平均股數(千股)
57933.0057819.0057634.0057550.0057469.0057309.0057097.0056870.0056802.0056771.00
稀釋平均股數(千股)
58755.0058776.0058696.0058717.0058427.0058524.0058218.0058103.0057541.0057597.00
還原基本每股稅後盈餘(元)
1.300.560.390.880.690.790.870.810.200.68
還原稀釋每股稅後盈餘(元)
1.290.550.390.870.680.780.850.790.200.67
還原基本平均股數(千股)
57,93357,81957,63457,55057,46957,30957,09756,87056,80256,771
還原稀釋平均股數(千股)
58,75558,77658,69658,71758,42758,52458,21858,10357,54157,597
EBITDA(千元)
102,03248,82051,61476,90458,96066,69666,01072,11131,70062,030

大家都在看

HOT